We prescribe on bloodwork, not a questionnaire. Preventive health in India doesn't look like preventive health in the US. Different bodies, different risks, different medicine. We built the platform India actually needs.
Oxford MBA. US citizen. Based in Mumbai by choice.
Tariq built arq because his father had a silent heart attack. Despite annual physicals, despite "normal" bloodwork, despite a cardiologist on speed dial—the warning signs were there. They just lived in the blindspots of Western preventive medicine protocols built for different populations.
That crisis led to a deeper insight: preventive health in India isn't about importing US playbooks. Indian bodies have different biomarker distributions. Different cardiovascular risk patterns. Different metabolic phenotypes. Different environmental stressors. Yet most preventive care still relies on one-size-fits-all reference ranges calibrated to European or North American populations.
arq was born to fix this. To build a preventive health platform that sees Indian bodies the way they actually are—grounded in South Asian epidemiology, calibrated to MASALA reference ranges, staffed by Indian doctors who understand the nuances of care in the subcontinent.
We don't use European or North American reference ranges. Every biomarker is interpreted through MASALA cohort data—250,000 South Asian adults who look like your actual population.
Board-certified MDs interpret every result. Algorithms assist; doctors decide. Your care is supervised by humans who understand Indian physiology, not black-box recommendations.
No generic wellness advice. Personalized protocols based on your blood, your family history, your risk trajectory. Adjusted quarterly based on your data.
| Approach | You Get | Why It Falls Short | arq. Does It Better |
|---|---|---|---|
| Hospital Checkup | Annual visit, basic labs | Reactive. Catches disease, not trajectory. | Quarterly panels, AI trend detection, continuity |
| Lab Test Online | Pick a panel, get results | No doctor context. No follow-up. | Clinical interpretation + consult + AI tracking |
| DTC Wellness App | Wearables, gamification | Entertainment, not medicine. Missing real biomarkers. | Precision panels + doctor oversight + records |
| Corporate Health | One-off annual screening | No follow-up, no trends, no personalization. | Continuous monitoring + protocol + adjustments |
Every doctor: MBBS + MD in specialty + 5+ years post-specialisation practice. Telemedicine is a feature, not a constraint.
Full compliance with Indian Ministry of Health's 2020 Telemedicine Practice Guidelines. Your data, privacy, consent—legally protected.
Digital Personal Data Protection Act 2023. End-to-end encryption. Never sold. Consent gates on every use. Regular audits.
Thyrocare, Dr Lal PathLabs. NABL accredited. Home collection in 24 hours. Results certified and reliable.
Our clinical engine is built on landmark South Asian studies. These cohorts shaped how we interpret every biomarker.
250,000+ South Asians. Reference ranges for lipids, glucose, inflammatory markers tailored to this population. The gold standard for biomarker interpretation in India.
Indian Council of Medical Research's nationwide diabetes surveillance. 80,000+ participants across urban and rural India. Epidemiology that shapes our metabolic risk models.
Cardiovascular disease and risk factors in South Asia. The blueprint for how we model cardiac risk in Indian populations.
40,000+ South Asians tracked for CVD, metabolic disease, mortality. Prospective Urban Rural Epidemiology data that informs our risk trajectories.
One panel. One doctor. A lifetime of data calibrated to your body, your population, your actual risk.